EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Improving Treatment Options in Schizophrenia:   Considering the Whole Patient
Editorial Archive

Improving Treatment Options in Schizophrenia: Considering the Whole Patient

This severe psychiatric disorder is twice as prevalent as Alzheimer’s disease and five times as prevalent as multiple sclerosis. But despite available treatments, sch...
Continue Reading →
FDA Suggests Reintroduction of Bovine-derived Heparin
Editorial Archive

FDA Suggests Reintroduction of Bovine-derived Heparin

During an advisory committee meeting with its Science Board in early June, the FDA suggested a reintroduction into the US market of bovine-derived heparin. Despite th...
Continue Reading →
JCS Interviews Tim Davis of Exco InTouch on the Use of Mobile Technology in Clinical Trials
Editorial Archive

JCS Interviews Tim Davis of Exco InTouch on the Use of Mobile Technology in Clinical Trials

The growth of mobile technology is now recognised by the pharmaceutical industry as an opportunity to change the way we interact with patients during clinical trials....
Continue Reading →
The Changing Face of Healthcare: Medical Apps & Crowdtesting
Editorial Archive

The Changing Face of Healthcare: Medical Apps & Crowdtesting

Because doctors and patients rely on the information and tools around cure, ensuring quality and safety are of paramount importance in gaining their trust in medical ...
Continue Reading →
Mobile App Development for Clinical Trials
Editorial Archive

Mobile App Development for Clinical Trials

Mobile devices and apps are set to become an essential part of clinical trials. Their connectivity, along with high processing speeds, high-quality visual displays, a...
Continue Reading →
Going Native? Deciding the Optimal App Approach for Smartphone eCOA
Editorial Archive

Going Native? Deciding the Optimal App Approach for Smartphone eCOA

It is estimated that over half of the global population owns a mobile phone, and with 680 million active mobile users of Facebook each month and 120 million using Twi...
Continue Reading →
Paediatric Clinical Trials in Central and Eastern Europe: Here and Now   
Editorial Archive

Paediatric Clinical Trials in Central and Eastern Europe: Here and Now  

Paediatric trials are a core part of clinical development. Not only is there a commercial incentive to develop paediatric treatments, but there is also a moral impera...
Continue Reading →
Implications of Paediatric Asthma in Clinical Trials
Editorial Archive

Implications of Paediatric Asthma in Clinical Trials

Asthma bronchiale is the most common and most frequent chronic illness in childhood. The global prevalence of paediatric asthma has continuously increased over the pa...
Continue Reading →
The Elements Requiring Particular Attention while Conducting Clinical Trials in a Paediatric Population
Editorial Archive

The Elements Requiring Particular Attention while Conducting Clinical Trials in a Paediatric Population

Children account for 20-40% of the global population depending on the region, but only a third of all medications are officially approved to treat children. Maxim Bel...
Continue Reading →
Setting the Standard for Central Labs in Asia Pacific and China
Editorial Archive

Setting the Standard for Central Labs in Asia Pacific and China

For more than two decades, central laboratories have played an important part in running global and large multi-regional clinical trials in Europe and the United Stat...
Continue Reading →
Quotient